240 related articles for article (PubMed ID: 26446085)
61. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers.
Gaillard MC; Roche S; Dion C; Tasmadjian A; Bouget G; Salort-Campana E; Vovan C; Chaix C; Broucqsault N; Morere J; Puppo F; Bartoli M; Levy N; Bernard R; Attarian S; Nguyen K; Magdinier F
Neurology; 2014 Aug; 83(8):733-42. PubMed ID: 25031281
[TBL] [Abstract][Full Text] [Related]
62. Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
[TBL] [Abstract][Full Text] [Related]
63. Screening in silico predicted remotely acting NF1 gene regulatory elements for mutations in patients with neurofibromatosis type 1.
Hamby SE; Reviriego P; Cooper DN; Upadhyaya M; Chuzhanova N
Hum Genomics; 2013 Aug; 7(1):18. PubMed ID: 23947441
[TBL] [Abstract][Full Text] [Related]
64. A focal domain of extreme demethylation within D4Z4 in FSHD2.
Hartweck LM; Anderson LJ; Lemmers RJ; Dandapat A; Toso EA; Dalton JC; Tawil R; Day JW; van der Maarel SM; Kyba M
Neurology; 2013 Jan; 80(4):392-9. PubMed ID: 23284062
[TBL] [Abstract][Full Text] [Related]
65. Analysis of the 4q35 chromatin organization reveals distinct long-range interactions in patients affected with Facio-Scapulo-Humeral Dystrophy.
Gaillard MC; Broucqsault N; Morere J; Laberthonnière C; Dion C; Badja C; Roche S; Nguyen K; Magdinier F; Robin JD
Sci Rep; 2019 Jul; 9(1):10327. PubMed ID: 31316120
[TBL] [Abstract][Full Text] [Related]
66. Does DNA Methylation Matter in FSHD?
Salsi V; Magdinier F; Tupler R
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121044
[TBL] [Abstract][Full Text] [Related]
67. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
[TBL] [Abstract][Full Text] [Related]
68. Facioscapulohumeral muscular dystrophy.
Statland J; Tawil R
Neurol Clin; 2014 Aug; 32(3):721-8, ix. PubMed ID: 25037087
[TBL] [Abstract][Full Text] [Related]
69. Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.
Hewitt JE
Hum Mol Genet; 2015 Oct; 24(R1):R17-23. PubMed ID: 26113644
[TBL] [Abstract][Full Text] [Related]
70. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091
[TBL] [Abstract][Full Text] [Related]
71. FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.
Gurzau AD; Chen K; Xue S; Dai W; Lucet IS; Ly TTN; Reversade B; Blewitt ME; Murphy JM
J Biol Chem; 2018 Jun; 293(25):9841-9853. PubMed ID: 29748383
[TBL] [Abstract][Full Text] [Related]
72. Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.
Jones TI; Himeda CL; Perez DP; Jones PL
Neuromuscul Disord; 2017 Mar; 27(3):221-238. PubMed ID: 28161093
[TBL] [Abstract][Full Text] [Related]
73. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
[TBL] [Abstract][Full Text] [Related]
74. Genotype-phenotype correlations in FSHD.
Zernov N; Skoblov M
BMC Med Genomics; 2019 Mar; 12(Suppl 2):43. PubMed ID: 30871534
[TBL] [Abstract][Full Text] [Related]
75. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
[TBL] [Abstract][Full Text] [Related]
76. Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis.
Leidenroth A; Sorte HS; Gilfillan G; Ehrlich M; Lyle R; Hewitt JE
Eur J Hum Genet; 2012 Sep; 20(9):999-1003. PubMed ID: 22378277
[TBL] [Abstract][Full Text] [Related]
77. Hybridization analysis of D4Z4 repeat arrays linked to FSHD.
Ehrlich M; Jackson K; Tsumagari K; Camaño P; Lemmers RJ
Chromosoma; 2007 Apr; 116(2):107-16. PubMed ID: 17131163
[TBL] [Abstract][Full Text] [Related]
78. Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.
Himeda CL; Jones TI; Jones PL
Antioxid Redox Signal; 2015 Jun; 22(16):1463-82. PubMed ID: 25336259
[TBL] [Abstract][Full Text] [Related]
79. FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation.
Mul K; Lemmers RJLF; Kriek M; van der Vliet PJ; van den Boogaard ML; Badrising UA; Graham JM; Lin AE; Brand H; Moore SA; Johnson K; Evangelista T; Töpf A; Straub V; Kapetanovic García S; Sacconi S; Tawil R; Tapscott SJ; Voermans NC; van Engelen BGM; Horlings CGC; Shaw ND; van der Maarel SM
Neurology; 2018 Aug; 91(6):e562-e570. PubMed ID: 29980640
[TBL] [Abstract][Full Text] [Related]
80. Facioscapulohumeral Disease as a myodevelopmental disease: Applying Ockham's razor to its various features.
Padberg GW; van Engelen BGM; Voermans NC
J Neuromuscul Dis; 2023; 10(3):411-425. PubMed ID: 36872787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
